Indeed, global SLE disease activity evaluated by PGA or SLEDAI was statistically associated with increased frequency of DN3, the reciprocal decreased frequency of DN1, and the associated decreased CD19 MFI in DN (Fig. 5A–D, Table 1A). This evidence concerns the gene CD19 and systemic lupus erythematosus.